You are here

Genentech

Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma

Fierce Pharma

Fri, 04/17/20 - 11:30 pm

Experts float Roche stroke drug Activase as potential COVID-19 therapy

Fierce Pharma

Fri, 03/27/20 - 08:20 pm

Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia

Motley Fool

Mon, 03/23/20 - 11:33 pm

clinical trials

Genentech's Esbriet Granted Breakthrough Therapy Designation for uILD

BioSpace

Wed, 03/4/20 - 10:47 am

breakthrough therapy

Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact

Fierce Biotech

Tue, 02/25/20 - 10:18 am

Bicycle Therapeutics

immuno-oncology

If biotech had a Mount Rushmore, whose heads would you chisel in the granite?

Stat

Tue, 02/4/20 - 10:04 am

Vertex Pharmaceuticals

George Rathmann

Roche's Tecentriq fails trial in form of urothelial cancer

Reuters

Fri, 01/24/20 - 10:08 am

clinical trials

urothelial cancer

Who are the 10 Most Innovative Biopharma Companies?

BioSpace

Fri, 01/17/20 - 11:41 pm

Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials

BioSpace

Thu, 12/19/19 - 12:45 pm

Arcus Biosciences

clinical trials

colorectal cancer

pancreatic cancer

Roche's flu med Xofluza drives drug resistance and may be a bad choice for kids, study says

Fierce Pharma

Wed, 11/27/19 - 12:34 pm

Bay Area Life Sciences Professionals Weigh In on Their Ideal Employers

BioSpace

Tue, 10/29/19 - 10:23 am

Gilead Sciences

Employees’ Perception vs. Employers’ Reality! New Research Shows the Top 3 Areas of Opportunity

BioSpace

Mon, 10/14/19 - 09:30 am

After more than a year, Gilead finds new chief medical officer

Biopharma Dive

Mon, 10/7/19 - 12:04 pm

Gilead Sciences

Roche AI Program Can Predict Progression of Diabetic Retinopathy

BioSpace

Tue, 09/24/19 - 07:11 pm

artificial intelligence

diabetic retinopathy

Can Synthetic Biology Make Insulin Faster, Better and Cheaper?

Forbes

Sat, 09/21/19 - 12:39 pm

Genentech submits a plan to nearly double its South San Francisco footprint

Endpoints

Fri, 09/20/19 - 10:45 am

As ‘big three’ oncology meds lose sales, Roche looks to file subcutaneous breast cancer combo

Pharmaforum

Fri, 09/13/19 - 10:56 am

HER2-positive breast cancer

FDA approves Rituxan biosimilar

Beckers Hospital Review

Tue, 07/23/19 - 07:40 pm

autoimmune disease

Roche's Genentech goes on deal spree, unveiling third deal on the same day

Endpoints

Tue, 07/16/19 - 10:57 am

Skyhawk Therapeutics

Convelo Therapeutics

Clover Therapeutics Launches With Eye on Age-Related Ocular Diseases

BioSpace

Thu, 07/11/19 - 05:28 pm

Clover Therapeutics

Pages